Fourth, kinetic parameters (such as serum calcitonin or CEA doubling time) are useful predictive markers of MTC tumor burden and are confirmed to correlate with the probability of disease relapse. The gene discussed is CALCA; the disease is medullary thyroid gland carcinoma.